基于人群的甲状腺癌手术后并发症评估
利用监测、流行病学和最终结果-医疗保险数据库,评估27912例1998至2011年间接受分化型或髓样甲状腺癌手术的患者,30天内一般并发症发生率为6.5%,1年内甲状腺手术特异性并发症发生率为12.3%,年龄>65岁、合并症评分高及晚期疾病患者风险最高。
要点
- 1820例(6.5%)发生一般术后并发症,3427例(12.3%)发生甲状腺手术特异性并发症。
- 年龄>65岁、Charlson/Deyo合并症评分1或≥2、区域或远处转移与并发症风险升高相关。
- 甲状腺癌手术并发症发生率高于预期,高危患者需努力减少并发症。
核心结论
- 甲状腺癌手术并发症发生率高于预期,高龄、合并症多及晚期疾病患者风险最高,需要努力减少并发症。
研究设计与样本
- 基于监测、流行病学和最终结果-医疗保险数据库的人群研究,纳入27912例1998至2011年间接受分化型或髓样甲状腺癌手术的患者,评估30天内一般并发症和1年内甲状腺手术特异性并发症,并进行多变量分析。
主要发现
- 总体1820例(6.5%)发生一般术后并发症,3427例(12.3%)发生甲状腺手术特异性并发症。
- 年龄>65岁患者一般并发症OR为2.61(95%CI 2.31至2.95),甲状腺手术特异性并发症OR为3.12(95%CI 2.85至3.42)。
- Charlson/Deyo合并症评分1分患者一般并发症OR为2.40(95%CI 1.66至3.49),甲状腺手术特异性并发症OR为1.88(95%CI 1.53至2.31)。
- Charlson/Deyo合并症评分≥2分患者一般并发症OR为7.05(95%CI 5.33至9.56),甲状腺手术特异性并发症OR为3.62(95%CI 3.11至4.25)。
- 区域疾病患者一般并发症OR为1.18(95%CI 1.03至1.35),甲状腺手术特异性并发症OR为1.31(95%CI 1.19至1.45);远处疾病患者一般并发症OR为2.83(95%CI 2.30至3.47),甲状腺手术特异性并发症OR为1.85(95%CI 1.54至2.21)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: As thyroid cancer incidence rises, more patients undergo thyroid surgery. Although postoperative complication rates have been reported in single institution studies, population-based data are limited. OBJECTIVE: To determine thyroid cancer surgery complication rates and identify at-risk populations. DESIGN/SETTING/PATIENTS: Using the Surveillance, Epidemiology, and End Results-Medicare database, we evaluated general complications within 30 days and thyroid surgery-specific complications within 1 year in 27,912 patients who underwent surgery for differentiated or medullary thyroid cancer between 1998 and 2011. Multivariable analyses of patient characteristics associated with postoperative complications were performed. MAIN OUTCOME MEASURES: General and thyroid surgery-specific complications. RESULTS: Overall, 1820 (6.5%) patients developed general postoperative complications and 3427 (12.3%) developed thyroid surgery-specific complications. In multivariable analyses, general and thyroid surgery-specific complications were significantly higher in patients >65 years [odds ratio (OR), 2.61; 95% confidence interval (CI), 2.31 to 2.95; OR, 3.12; 95% CI, 2.85 to 3.42], those with a Charlson/Deyo comorbidity score of 1 (OR, 2.40; 95% CI, 1.66 to 3.49; OR, 1.88; 95% CI, 1.53 to 2.31) and ≥2 (OR, 7.05; 95% CI, 5.33 to 9.56; OR, 3.62; 95% CI, 3.11 to 4.25), and those with regional (OR, 1.18; 95% CI, 1.03 to 1.35; OR, 1.31; 95% CI, 1.19 to 1.45) or distant disease (OR, 2.83; 95% CI, 2.30 to 3.47; OR, 1.85; 95% CI, 1.54 to 2.21), respectively. CONCLUSIONS: The rates of thyroid cancer surgery complications are higher than predicted, and patients with older age, more comorbidities, and advanced disease are at greatest risk. Efforts to reduce complications are needed.
引用
- Papaleontiou M, Hughes DT, Guo C, et al. Population-Based Assessment of Complications Following Surgery for Thyroid Cancer. J Clin Endocrinol Metab. 2017. PMID: 28460061. doi:10.1210/jc.2017-00255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。